Once-monthly galcanezumab for the prevention of migraine in adults: an evidence-based descriptive review and potential place in therapy

Lupi C, Guerzoni S, Negro A, Benemei S

Therapeutics and Clinical Risk Management 2019, 15:557-569

Published Date: 11 April 2019